Letrozole in the management of advanced ovarian cancer: an old drug as a new targeted therapy | International Journal of Gynecologic Cancer

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via your Society

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Article metrics

Review

Letrozole in the management of advanced ovarian cancer: an old drug as a new targeted therapy

Online download statistics by month:

Online download statistics by month: March 2020 to March 2023

	Abstract	Full	Pdf
Mar 2020	184	16	9
Apr 2020	1267	47	31
May 2020	327	25	19
Jun 2020	155	7	6
Jul 2020	1457	38	21
Aug 2020	518	12	7
Sep 2020	406	7	5
Oct 2020	472	4	1
Nov 2020	491	3	3
Dec 2020	560	19	2
Jan 2021	633	13	4
Feb 2021	506	16	3
Mar 2021	625	5	3
Apr 2021	632	5	5
May 2021	231	4	3
Jun 2021	25	12	5
Jul 2021	12	3	0
Aug 2021	9	2	1
Sep 2021	13	5	2
Oct 2021	339	8	3
Nov 2021	384	3	0
Dec 2021	485	5	7
Jan 2022	390	7	1
Feb 2022	290	3	5
Mar 2022	534	16	7
Apr 2022	408	5	3
May 2022	487	9	2
Jun 2022	398	16	1
Jul 2022	356	10	0
Aug 2022	396	23	1
Sep 2022	398	10	2
Oct 2022	435	4	4
Nov 2022	399	13	6
Dec 2022	245	5	2
Jan 2023	403	3	0
Feb 2023	385	3	1
Mar 2023	295	1	1
Total	15550	387	176